<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31624127</article-id>
<article-id pub-id-type="pmc">6842590</article-id>
<article-id pub-id-type="publisher-id">201911385</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1911385116</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Medical Sciences</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zammataro</surname>
<given-names>Luca</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopez</surname>
<given-names>Salvatore</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bellone</surname>
<given-names>Stefania</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pettinella</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonazzoli</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perrone</surname>
<given-names>Emanuele</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Siming</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menderes</surname>
<given-names>Gulden</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Altwerger</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Chanhee</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeybek</surname>
<given-names>Burak</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bianchi</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manzano</surname>
<given-names>Aranzazu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manara</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cocco</surname>
<given-names>Emiliano</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buza</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hui</surname>
<given-names>Pei</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>Serena</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-4661-9979</contrib-id>
<name>
<surname>Ravaggi</surname>
<given-names>Antonella</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6380-6181</contrib-id>
<name>
<surname>Bignotti</surname>
<given-names>Eliana</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romani</surname>
<given-names>Chiara</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Todeschini</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zanotti</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Odicino</surname>
<given-names>Franco</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pecorelli</surname>
<given-names>Sergio</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Donzelli</surname>
<given-names>Carla</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ardighieri</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Angioli</surname>
<given-names>Roberto</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>i</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raspagliesi</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scambia</surname>
<given-names>Giovanni</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>k</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Jungmin</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>l</sup>
</xref>
<xref ref-type="aff" rid="aff13">
<sup>m</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Weilai</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bilguvar</surname>
<given-names>Kaya</given-names>
</name>
<xref ref-type="aff" rid="aff14">
<sup>n</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3596-4515</contrib-id>
<name>
<surname>Alexandrov</surname>
<given-names>Ludmil B.</given-names>
</name>
<xref ref-type="aff" rid="aff15">
<sup>o</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silasi</surname>
<given-names>Dan-Arin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Gloria S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ratner</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Azodi</surname>
<given-names>Masoud</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwartz</surname>
<given-names>Peter E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pirazzoli</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="aff16">
<sup>p</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stiegler</surname>
<given-names>Amy L.</given-names>
</name>
<xref ref-type="aff" rid="aff17">
<sup>q</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boggon</surname>
<given-names>Titus J.</given-names>
</name>
<xref ref-type="aff" rid="aff17">
<sup>q</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lifton</surname>
<given-names>Richard P.</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schlessinger</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="aff17">
<sup>q</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santin</surname>
<given-names>Alessandro D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Obstetrics, Gynecology &amp; Reproductive Sciences, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff2"><sup>b</sup>Department of Experimental and Clinical Medicine, <institution>Magna Graecia University</institution>, 88100 Catanzaro, <country>Italy</country>;</aff>
<aff id="aff3"><sup>c</sup>Institute of Obstetrics and Gynecology, <institution>Università Cattolica del Sacro Cuore</institution>, 00168 Rome, <country>Italy</country>;</aff>
<aff id="aff4"><sup>d</sup>Department of Human Genetics, <institution>The University of Chicago</institution>, Chicago, <addr-line>IL</addr-line> 60637;</aff>
<aff id="aff5"><sup>e</sup>Human Oncology and Pathogenesis Program, <institution>Memorial Sloan Kettering Cancer Center</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff6"><sup>f</sup>Department of Pathology, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06520;</aff>
<aff id="aff7"><sup>g</sup>“Angelo Nocivelli” Institute of Molecular Medicine, Department of Obstetrics, &amp; Gynecology, <institution>University of Brescia</institution>, 25100 Brescia, <country>Italy</country>;</aff>
<aff id="aff8"><sup>h</sup>Department of Pathology, <institution>University of Brescia</institution>, 25100 Brescia, <country>Italy</country>;</aff>
<aff id="aff9"><sup>i</sup>Department of Gynecology and Obstetrics, <institution>Università Campus Bio-Medico di Roma</institution>, 00128 Rome, <country>Italy</country>;</aff>
<aff id="aff10"><sup>j</sup><institution>Department of Gynecology Oncology</institution>, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori di Milano, 20133 Milan, <country>Italy</country>;</aff>
<aff id="aff11"><sup>k</sup>Unit of Gynecologic Oncology, Department Woman and Child Health Sciences and Public Health, <institution>Fondazione Policlinico Universitario A. Gemelli</institution> Istituto di Ricovero e Cura a Carattere Scientifico, 00168 Rome, <country>Italy</country>;</aff>
<aff id="aff12"><sup>l</sup>Department of Genetics, <institution>The Rockefeller University</institution>, New York, <addr-line>NY</addr-line> 10065;</aff>
<aff id="aff13"><sup>m</sup>Department of Biomedical Sciences, <institution>Korea University College of Medicine</institution>, 02841 Seoul, <country>Korea</country>;</aff>
<aff id="aff14"><sup>n</sup>Department of Genetics, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff15"><sup>o</sup>Department of Cellular and Molecular Medicine, <institution>University of California San Diego</institution>, La Jolla, <addr-line>CA</addr-line> 92093;</aff>
<aff id="aff16"><sup>p</sup>Yale Cancer Center, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff17"><sup>q</sup>Department of Pharmacology, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06520</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence may be addressed. Email: <email>Joseph.Schlessinger@Yale.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Contributed by Joseph Schlessinger, September 16, 2019 (sent for review July 8, 2019; reviewed by John A. Martignetti and Dan Theodorescu)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: L. Zammataro, E. Bonazzoli, R.P.L., J.S., and A.D.S. designed research; S.L., S.B., F.P., E. Bonazzoli, E.P., G.M., G.A., B.Z., A.B., A.M., P.M., E.C., N.B., P.H., S.W., A.R., E. Bignotti, C.R., P.T., L. Zanotti, C.D., L.A., L.B.A., and A.L.S. performed research; S.L., F.P., C.H., F.O., S.P., R.A., F.R., G.S., K.B., D.-A.S., G.S.H., E.R., M.A., P.E.S., V.P., and A.L.S. contributed new reagents/analytic tools; L. Zammataro, S.L., S.Z., J.C., W.D., T.J.B., R.P.L., J.S., and A.D.S. analyzed data; and L. Zammataro, S.L., S.Z., J.S., and A.D.S. wrote the paper.</p>
</fn>
<fn fn-type="con">
<p>Reviewers: J.A.M., Mount Sinai School of Medicine; and D.T., Cedars-Sinai Medical Center.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>L. Zammataro and S.L. contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no competing interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>5</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>116</volume>
<issue>45</issue>
<fpage>22730</fpage>
<lpage>22736</lpage>
<permissions>
<copyright-year>2019</copyright-year>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://www.pnas.org/site/aboutpnas/licenses.xhtml</ali:license_ref>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201911385.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>The development of novel, effective treatments for patients with advanced/recurrent cervical cancer remains an unmet medical need. Using whole-exome sequencing, we identified multiple genes with recurrent alterations in cervical cancer, including the ERBB2/PI3K/AKT/mTOR, apoptosis, chromatin remodeling, and cell cycle pathways. Using fully sequenced cell lines and xenografts, we found pan-HER (afatinib/neratinib) and PIK3CA (copanlisib) inhibitors to be active, but only transiently effective in controlling the in vivo growth of PIK3CA-mutated cervical tumor xenografts. In contrast, the combination of irreversible pan-HER kinase and PIK3CA inhibitors was highly synergistic and able to induce durable regression of xenografts harboring derangements in the ERBB2/PI3K/AKT/mTOR pathway in vivo. These findings suggest a large subset of cervical tumors (&gt;70%) might benefit from existing ERBB2/PIK3CA/AKT/mTOR-targeted drugs.</p>
</abstract>
<abstract>
<p>The prognosis of advanced/recurrent cervical cancer patients remains poor. We analyzed 54 fresh-frozen and 15 primary cervical cancer cell lines, along with matched-normal DNA, by whole-exome sequencing (WES), most of which harboring Human-Papillomavirus-type-16/18. We found recurrent somatic missense mutations in 22 genes (including PIK3CA, ERBB2, and GNAS) and a widespread APOBEC cytidine deaminase mutagenesis pattern (TCW motif) in both adenocarcinoma (ACC) and squamous cell carcinomas (SCCs). Somatic copy number variants (CNVs) identified 12 copy number gains and 40 losses, occurring more often than expected by chance, with the most frequent events in pathways similar to those found from analysis of single nucleotide variants (SNVs), including the ERBB2/PI3K/AKT/mTOR, apoptosis, chromatin remodeling, and cell cycle. To validate specific SNVs as targets, we took advantage of primary cervical tumor cell lines and xenografts to preclinically evaluate the activity of pan-HER (afatinib and neratinib) and PIK3CA (copanlisib) inhibitors, alone and in combination, against tumors harboring alterations in the ERBB2/PI3K/AKT/mTOR pathway (71%). Tumors harboring <italic>ERBB2</italic> (5.8%) domain mutations were significantly more sensitive to single agents afatinib or neratinib when compared to wild-type tumors in preclinical in vitro and in vivo models (<italic>P</italic> = 0.001). In contrast, pan-HER and PIK3CA inhibitors demonstrated limited in vitro activity and were only transiently effective in controlling in vivo growth of PIK3CA-mutated cervical cancer xenografts. Importantly, combinations of copanlisib and neratinib were highly synergistic, inducing long-lasting regression of tumors harboring alterations in the ERBB2/PI3K/AKT/mTOR pathway. These findings define the genetic landscape of cervical cancer, suggesting that a large subset of cervical tumors might benefit from existing ERBB2/PIK3CA/AKT/mTOR-targeted drugs.</p>
</abstract>
<kwd-group>
<kwd>cervical cancer</kwd>
<kwd>PIK3CA</kwd>
<kwd>HER2/neu</kwd>
<kwd>neratinib</kwd>
<kwd>copanlisib</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Cancer Institute (NCI)<named-content content-type="funder-id">100000054</named-content></funding-source>
<award-id rid="sp1">CA-16359</award-id>
<principal-award-recipient>Alessandro D Santin</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>